BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23770250)

  • 1. Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays.
    Duquesnoy RJ; Marrari M; Jelenik L; Zeevi A; Claas FH; Mulder A
    Hum Immunol; 2013 Oct; 74(10):1271-9. PubMed ID: 23770250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies.
    Duquesnoy RJ; Marrari M; Mulder A; Claas FH; Mostecki J; Balazs I
    Hum Immunol; 2012 Mar; 73(3):267-77. PubMed ID: 22227099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
    Duquesnoy RJ; Marrari M
    Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
    Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
    Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monoclonal antibody reactivity with human leukocyte antigen class I epitopes defined by pairs of mismatched eplets and self-eplets.
    Marrari M; Mostecki J; Mulder A; Claas F; Balazs I; Duquesnoy RJ
    Transplantation; 2010 Dec; 90(12):1468-72. PubMed ID: 21063243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity.
    Duquesnoy RJ
    Int J Immunogenet; 2012 Feb; 39(1):1-9. PubMed ID: 21981757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens.
    Marrari M; Duquesnoy RJ
    Tissue Antigens; 2009 Aug; 74(2):134-46. PubMed ID: 19497040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen epitope antigenicity and immunogenicity.
    Duquesnoy RJ
    Curr Opin Organ Transplant; 2014 Aug; 19(4):428-35. PubMed ID: 25010064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First report on the antibody verification of HLA-ABC epitopes recorded in the website-based HLA Epitope Registry.
    Duquesnoy RJ; Marrari M; Mulder A; Sousa LC; da Silva AS; do Monte SJ
    Tissue Antigens; 2014 Jun; 83(6):391-400. PubMed ID: 24828056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies.
    Ravindranath MH; Pham T; El-Awar N; Kaneku H; Terasaki PI
    Mol Immunol; 2011 Jan; 48(4):423-30. PubMed ID: 21145594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodies.
    Lachmann N; Todorova K; Schulze H; Schönemann C
    Transplantation; 2013 Mar; 95(5):694-700. PubMed ID: 23354296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies.
    Golan MD; Burger R; Loos M
    J Immunol; 1982 Aug; 129(2):445-7. PubMed ID: 6177765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q assay for the detection of complement fixing antibody to HLA antigens.
    Chen G; Tyan DB
    Methods Mol Biol; 2013; 1034():305-11. PubMed ID: 23775744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update of the HLA class I eplet database in the website based registry of antibody-defined HLA epitopes.
    Duquesnoy RJ
    Tissue Antigens; 2014 Jun; 83(6):382-90. PubMed ID: 24828055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays.
    Visentin J; Vigata M; Daburon S; Contin-Bordes C; Fremeaux-Bacchi V; Dromer C; Billes MA; Neau-Cransac M; Guidicelli G; Taupin JL
    Transplantation; 2014 Sep; 98(6):625-31. PubMed ID: 25058376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens.
    El-Awar N; Lee JH; Tarsitani C; Terasaki PI
    Hum Immunol; 2007 Mar; 68(3):170-80. PubMed ID: 17349872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structurally based approach to determine HLA compatibility at the humoral immune level.
    Duquesnoy RJ
    Hum Immunol; 2006 Nov; 67(11):847-62. PubMed ID: 17145365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen epitope analysis to assess complement- and non-complement-binding donor-specific antibody repertoire in a pediatric heart transplant recipient.
    Zeevi A; Marrari M; Feingold B; Webber S; Duquesnoy RJ
    Hum Immunol; 2012 Jan; 73(1):48-51. PubMed ID: 22100305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA epitope based matching for transplantation.
    Duquesnoy RJ
    Transpl Immunol; 2014 Jun; 31(1):1-6. PubMed ID: 24769079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant.
    Resse M; Paolillo R; Casamassimi A; Cavalca F; Fiorito C; Maiello C; Napoli C
    Hum Immunol; 2013 Aug; 74(8):937-41. PubMed ID: 23628396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.